Study Watch AF Detection At Home

V

Verily Life Sciences

Status

Completed

Conditions

Atrial Fibrillation

Treatments

Device: Study Watch
Device: Zio XT

Study type

Observational

Funder types

Industry

Identifiers

NCT04546763
102238

Details and patient eligibility

About

This is a multi-center, prospective, non-randomized study to evaluate the performance of the study watch PPG algorithm in detecting irregular rhythms suggestive of atrial fibrillation (AF) in subjects at risk of having an event of AF in the free living (home) environment.

Enrollment

117 patients

Sex

All

Ages

22+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • At least 22 years old
  • Able to read and speak English
  • Able and willing to sign written Informed Consent
  • Interest in participating in the study
  • At risk of having an AF event, as determined by having a diagnosis of paroxysmal AF (PAF) and meeting one of the following: (a) scheduled or to be scheduled to undergo AF ablation, (b) with implantable loop recorder (ILR), implantable cardioverter defibrillator (ICD), permanent pacemaker (PPM), holter monitor, or adhesive monitoring patch with documented AF burden of ≥25% in the 3 months prior to consent date, (c) CHA2DS2VASc ≥3, (d) Left atrial diameter ≥4.4 cm
  • Without significant limitation in ability to participate in the study, in the opinion of the investigator

Exclusion criteria

  • Currently in a paced rhythm
  • Currently on class Ic or class III antiarrhythmic medication that has been successful in eliminating AF (no documented AF of more than 30 seconds since the initiation of the medication)
  • Had successful AF ablation (no documented AF of more than 30 seconds post procedure)
  • Known severe allergy to nickel or metal jewelry
  • Known allergic reaction to adhesives or hydrogels or with family history of adhesive skin allergies
  • Are diagnosed with persistent AF
  • Use of implantable neuro-stimulator
  • Open injury or rash where the study device or comparator will be worn

Trial design

117 participants in 1 patient group

Paroxysmal Atrial Fibrillation Patients
Description:
This will be a single arm study of patients with paroxysmal atrial fibrillation. Subjects will be wearing the Study Watch and Zio XT Patch concurrently for up to 14 days.
Treatment:
Device: Zio XT
Device: Study Watch

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems